Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment

NCT: NCT07779330 · NOT_YET_RECRUITING

NCT IDNCT07779330
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2029-12
SponsorNational University Hospital, Singapore (OTHER)
First posted
Last updated

Brief Summary

This proposal seeks to carry out a prospective, single-arm open label study aimed at sustaining treatment-resistant depression (TRD) response in patients with TRD who had responded to prior individualized resting-state functional connectivity (rs-FC)-guided intermittent theta burst stimulation (iTBS). It also seeks to detect and predict relapse risk by integrating rs-FC iTBS with a TMS-adapted needs-based symptom-titrated algorithm based longitudinal ECT (STABLE) maintenance scheduling algorithm, and passive digital biomarkers.

Frequently Asked Questions

What is Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment?

Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment is a clinical trial registered under NCT07779330. Current status: NOT_YET_RECRUITING.

What is the status of NCT07779330?

The current status of NCT07779330 (Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment) is: NOT_YET_RECRUITING.

When did Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment start?

Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.